Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Cancer, Combined Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03184571
What this trial is testing

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer MetastaticNSCLC Stage IVAdenocarcinoma of Lung
BerGenBio ASA 99
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT05077709
What this trial is testing

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Who this might be right for
Lung Cancer Non Small CellHead and Neck Squamous Cell CarcinomaUrothelial Carcinoma Bladder
IO Biotech 63
Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Early research (Phase 1)Study completedNCT05867121
What this trial is testing

Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma
Genentech, Inc. 102
Testing effectiveness (Phase 2)UnknownNCT00178698
What this trial is testing

Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

Who this might be right for
Neuroendocrine CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+1 more
The University of Texas Health Science Center, Houston 36
Testing effectiveness (Phase 2)Looking for participantsNCT05956587
What this trial is testing

SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 121
Early research (Phase 1)Study completedNCT00528619
What this trial is testing

Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 96
Early research (Phase 1)Study completedNCT03502330
What this trial is testing

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Who this might be right for
Advanced MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Yale University 42
Early research (Phase 1)Active Not RecruitingNCT05537740
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 129
Early research (Phase 1)Study completedNCT03468426
What this trial is testing

Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

Who this might be right for
Non-squamous, Non-Small-Cell Lung CancerNeoplasms
Boehringer Ingelheim 252
Testing effectiveness (Phase 2)Looking for participantsNCT06814496
What this trial is testing

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Who this might be right for
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
University of Arizona 30
Testing effectiveness (Phase 2)Looking for participantsNCT07563738
What this trial is testing

A 2-part Phase 1/2 Open-label Trial on ODM-212

Who this might be right for
MesotheliomaPancreatic CancerNSCLC (Advanced Non-small Cell Lung Cancer)
Orion Corporation, Orion Pharma 229
Testing effectiveness (Phase 2)UnknownNCT01410214
What this trial is testing

Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations

Who this might be right for
Non-small Cell Lung Cancer Stage IIIA
Chinese Lung Cancer Surgical Group 80
Testing effectiveness (Phase 2)Study completedNCT03761914
What this trial is testing

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Who this might be right for
Acute Myelogenous LeukemiaOvarian CancerColorectal Cancer+2 more
Sellas Life Sciences Group 26
Early research (Phase 1)Not Yet RecruitingNCT07713732
What this trial is testing

TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors

Who this might be right for
Small Cell Lung Cancer ( SCLC )Neuroendocrine CancerMalignant Pleural Mesotheliomas (Mpm)+1 more
Treeline Biosciences, Inc. 120
Early research (Phase 1)Looking for participantsNCT07376707
What this trial is testing

TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
CRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma+1 more
Hefei TG ImmunoPharma Co., Ltd. 194
Early research (Phase 1)Study completedNCT01307267
What this trial is testing

PF-05082566 As A Single Agent And In Combination With Rituximab

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more
Pfizer 190
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Study completedNCT00601796
What this trial is testing

Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 24
Next Page